Hip & pelvis

The Korean Hip Society (대한고관절학회)
권호 표지
DOI QR코드

DOI QR Code

Diagnosis and Management of Sarcopenia after Hip Fracture Surgery: Current Concept Review

  • Jun-Il Yoo (Department of Orthopaedic Surgery, Gyeongsang National University Hospital) ;
  • Jung-Taek Kim (Department of Orthopedic Surgery, Ajou Medical Center, Ajou University School of Medicine) ;
  • Chan Ho Park (Department of Orthopedic Surgery, Yeungnam University Medical Center) ;
  • Yonghan Cha (Department of Orthopaedic Surgery, Daejeon Eulji Medical Center, Eulji University School of Medicine)
  • Received : 2021.07.13
  • Accepted : 2021.10.09
  • Published : 2022.03.31
Download PDF
⟨ Previous Next ⟩

Abstract

To date, family medicine and internal medicine fields have been responsible for defining, researching, and development of treatments for sarcopenia, focusing mainly on diabetes and metabolic diseases. Therefore, application of current guidelines for diagnosis of sarcopenia which differ according to continent to patients with hip fractures in the orthopedic field is difficult. The purpose of this review was to understand the recent consensus on the definition and diagnosis of sarcopenia and to highlight the importance of research and future research opportunities on the management of sarcopenia in patients with hip fractures by orthopedic surgeons. The global prevalence of sarcopenia in patients with hip fractures is statistically significant. Despite establishment of various therapeutic and diagnostic criteria for osteoporosis in the clinical field, there are no clear, useful diagnostic criteria for sarcopenia in the clinical field. In particular, few studies on the evaluation and treatment of sarcopenia in patients with hip fractures have been reported. In addition, the quality of life of postoperative patients with hip fractures could be significantly improved by development of precise assessment for muscle regeneration and rehabilitation in the operating room.

Keywords

Acknowledgement

This work was supported by a grant (No. NRF-2019R1F1A1059208) from the National Research Foundation of Korea (NRF) funded by the Korean government (MEST).

References

  1. Palus S, Springer JI, Doehner W, et al. Models of sarcopenia: short review. Int J Cardiol. 2017;238:19-21.
  2. Xie WQ, He M, Yu DJ, et al. Mouse models of sarcopenia: classification and evaluation. J Cachexia Sarcopenia Muscle. 2021;12:538-54.
  3. Robinson S, Cooper C, Aihie Sayer A. Nutrition and sarcopenia: a review of the evidence and implications for preventive strategies. J Aging Res. 2012;2012:510801.
  4. Anker SD, Morley JE, von Haehling S. Welcome to the ICD10 code for sarcopenia. J Cachexia Sarcopenia Muscle. 2016;7:512-4.
  5. Kim TN, Choi KM. Sarcopenia: definition, epidemiology, and pathophysiology. J Bone Metab. 2013;20:1-10.
  6. Chen LK, Woo J, Assantachai P, et al. Asian Working Group for Sarcopenia: 2019 consensus update on sarcopenia diagnosis and treatment. J Am Med Dir Assoc. 2020;21:300-7.e2.
  7. Faron A, Sprinkart AM, Kuetting DLR, et al. Body composition analysis using CT and MRI: intra-individual intermodal comparison of muscle mass and myosteatosis. Sci Rep. 2020;10:11765.
  8. Spiro AJ, Hoang TD, Shakir MKM. Artifacts affecting dualenergy x-ray absorptiometry measurements. AACE Clin Case Rep. 2019;5:e263-6.
  9. Yu R, Leung J, Woo J. Incremental predictive value of sarcopenia for incident fracture in an elderly Chinese cohort: results from the Osteoporotic Fractures in Men (MrOs) Study. J Am Med Dir Assoc. 2014;15:551-8.
  10. Yoshimura N, Muraki S, Oka H, et al. Is osteoporosis a predictor for future sarcopenia or vice versa? Four-year observations between the second and third ROAD study surveys. Osteoporos Int. 2017;28:189-99.
  11. Woo J, Leung J, Morley JE. Defining sarcopenia in terms of incident adverse outcomes. J Am Med Dir Assoc. 2015; 16:247-52.
  12. Yu R, Leung J, Woo J. Sarcopenia combined with FRAX probabilities improves fracture risk prediction in older Chinese men. J Am Med Dir Assoc. 2014;15:918-23.
  13. Yoo JI, Ha YC, Kwon HB, Lee YK, Koo KH, Yoo MJ. High prevalence of sarcopenia in Korean patients after hip fracture: a case-control study. J Korean Med Sci. 2016;31:1479-84.
  14. Hida T, Ishiguro N, Shimokata H, et al. High prevalence of sarcopenia and reduced leg muscle mass in Japanese patients immediately after a hip fracture. Geriatr Gerontol Int. 2013;13:413-20.
  15. Di Monaco M, Castiglioni C, Vallero F, Di Monaco R, Tappero R. Sarcopenia is more prevalent in men than in women after hip fracture: a cross-sectional study of 591 inpatients. Arch Gerontol Geriatr. 2012;55:e48-52.
  16. Gonzalez-Montalvo JI, Alarcon T, Gotor P, et al. Prevalence of sarcopenia in acute hip fracture patients and its influence on short-term clinical outcome. Geriatr Gerontol Int. 2016;16:1021-7.
  17. Chen LK, Liu LK, Woo J, et al. Sarcopenia in Asia: consensus report of the Asian Working Group for Sarcopenia. J Am Med Dir Assoc. 2014;15:95-101.
  18. Hunter GR, Singh H, Carter SJ, Bryan DR, Fisher G. Sarcopenia and its implications for metabolic health. J Obes. 2019;2019:8031705.
  19. Cruz-Jentoft AJ, Baeyens JP, Bauer JM, et al. Sarcopenia: European consensus on definition and diagnosis: report of the European Working Group on Sarcopenia in Older People. Age Ageing. 2010;39:412-23.
  20. Boutin RD, Lenchik L. Value-added opportunistic CT: insights into osteoporosis and sarcopenia. AJR Am J Roentgenol. 2020;215:582-94.
  21. Birkbeck MG, Blamire AM, Whittaker RG, Sayer AA, Dodds RM. The role of novel motor unit magnetic resonance imaging to investigate motor unit activity in ageing skeletal muscle. J Cachexia Sarcopenia Muscle. 2021;12:17-29.
  22. Nunez-Peralta C, Alonso-Perez J, Diaz-Manera J. The increasing role of muscle MRI to monitor changes over time in untreated and treated muscle diseases. Curr Opin Neurol. 2020;33:611-20.
  23. Carlier PG, Marty B, Scheidegger O, et al. Skeletal muscle quantitative nuclear magnetic resonance imaging and spectroscopy as an outcome measure for clinical trials. J Neuromuscul Dis. 2016;3:1-28.
  24. Ogawa M, Lester R, Akima H, Gorgey AS. Quantification of intermuscular and intramuscular adipose tissue using magnetic resonance imaging after neurodegenerative disorders. Neural Regen Res. 2017;12:2100-5.
  25. Hashimoto F, Kakimoto A, Ota N, Ito S, Nishizawa S. Automated segmentation of 2D low-dose CT images of the psoas-major muscle using deep convolutional neural networks. Radiol Phys Technol. 2019;12:210-5.
  26. Ahn DW, Jeong JB, Kang J, et al. Fatty liver is an independent risk factor for gallbladder polyps. World J Gastroenterol. 2020;26:6979-92.
  27. Byun SE, Kim S, Kim KH, Ha YC. Psoas cross-sectional area as a predictor of mortality and a diagnostic tool for sarcopenia in hip fracture patients. J Bone Miner Metab. 2019;37:871-9.
  28. Kim S, Kim M, Won CW. Validation of the Korean version of the SARC-F questionnaire to assess sarcopenia: Korean Frailty and Aging Cohort Study. J Am Med Dir Assoc. 2018;19:40-5.e1.
  29. Ha YC, Won Won C, Kim M, Chun KJ, Yoo JI. SARC-F as a useful tool for screening sarcopenia in elderly patients with hip fractures. J Nutr Health Aging. 2020;24:78-82.
  30. Ha YC, Yoo JI, Park YJ, Lee CH, Park KS. Measurement of uncertainty using standardized protocol of hand grip strength measurement in patients with sarcopenia. J Bone Metab. 2018;25:243-9.
  31. Yoo JI, Byun H, Kim HS, Jang YJ, Lee CH. Evaluating postoperative muscle strength using surface electromyography in hip fracture patient. J Bone Metab. 2020;27:125-32.
  32. Rogers-Soeder TS, Peters KE, Lane NE, et al. Dietary intake, D3Cr muscle mass, and appendicular lean mass in a cohort of older men. J Gerontol A Biol Sci Med Sci. 2020;75:1353-61.
  33. Orwoll ES, Peters KE, Hellerstein M, Cummings SR, Evans WJ, Cawthon PM. The importance of muscle versus fat mass in sarcopenic obesity: a re-evaluation using D3-creatine muscle mass versus DXA lean mass measurements. J Gerontol A Biol Sci Med Sci. 2020;75:1362-8.
  34. Yoo JI, Ha YC, Kim M, et al. Translation and validation of the Korean version of the Sarcopenia Quality of Life (SarQoLK®) questionnaire and applicability with the SARC-F screening tool. Qual Life Res. 2021;30:603-11.
  35. Oh MK, Yoo JI, Byun H, et al. Efficacy of combined antigravity treadmill and conventional rehabilitation after hip fracture in patients with sarcopenia. J Gerontol A Biol Sci Med Sci. 2020;75:e173-81.
  36. Lim SK, Beom J, Lee SY, et al. Association between sarcopenia and fall characteristics in older adults with fragility hip fracture. Injury. 2020;51:2640-7.